Investigating how early life allergen exposure affects asthma development
Age-related mechanisms of T helper 2 memory in the early lung
This study is looking at how being around allergens when you're young can affect the immune system in your lungs, specifically how certain immune cells develop, and it hopes to find new ways to stop allergic asthma from getting worse as kids grow up.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10845558 on NIH RePORTER |
What this research studies
This research explores the mechanisms behind allergic asthma, particularly focusing on how exposure to allergens in early life influences the establishment of specific immune cells known as T helper 2 resident memory cells (Th2-TRMs) in the lungs. The study examines the interaction between sympathetic nerves and CD4+ T cells in the developing lungs of infants and young children. By understanding these interactions, the research aims to identify new ways to prevent the progression of allergic asthma from childhood into adulthood.
Who could benefit from this research
Good fit: Ideal candidates for this research are children and young adults who have a history of allergic asthma or are at risk of developing it due to early life allergen exposure.
Not a fit: Patients who do not have allergic asthma or have not been exposed to relevant allergens in early life may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating allergic asthma, particularly in children.
How similar studies have performed: Previous research has shown promising results in understanding the role of immune cells in asthma, but this specific approach to studying early life exposure and its long-term effects is relatively novel.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Ai, Xingbin — Massachusetts General Hospital
- Study coordinator: Ai, Xingbin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.